ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2019

Improvements in Lung Function with Nebulized Revefenacin in the Treatment of Patients with Moderate to Very Severe COPD: Results from Two Replicate Phase III Clinical Trials.

Gary T Ferguson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.